optimizing lesion cross ability and accuracy by reducing ...€¦ · speaker name: pawanrat...
TRANSCRIPT
![Page 1: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/1.jpg)
Optimizing lesion cross ability
and accuracy by reducing
fluoroscopy time and radiation
exposure
Pawanrat Kranokpiraksa, MD
Interventional Radiology
Chulalongkorn University Bangkok, Thailand
![Page 2: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/2.jpg)
Disclosure
Speaker name: Pawanrat Kranokpiraksa
I have the following potential conflicts of interest to report:
Consulting
Employment in industry
Stockholder of a healthcare company
Owner of a healthcare company
The physician has been compensated by Bard Peripheral Vascular,
Inc. to participate in this presentation.
I do not have any potential conflict of interest
X
![Page 3: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/3.jpg)
GEOALIGN Marking system
•What is it?
•How does it work?
•What are the benefits?
![Page 4: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/4.jpg)
BPV/LTNX/1015/0002
Description External Ruler on the Catheter Shaft
![Page 5: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/5.jpg)
*When the catheter is exposed to the vascular system,
the location of the balloon should be confirmed while
under high quality fluoroscopic observation
BPV/LTNX/1015/0002
Alignment Benefit Designed to Facilitate Repeat Catheter Alignment at the Lesion*
![Page 6: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/6.jpg)
* The LUTONIX® Catheter should always
be manipulated under fluoroscopic
observation when in the body
BPV/LTNX/1015/0002
Designed to Facilitate Repeat Catheter Alignment at the Lesion*
Alignment Benefit
![Page 7: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/7.jpg)
Designed to Increase Procedure Efficiency by Minimizing
Fluoroscopy Exposure*
Radiation Consideration
Pre-Clinical Animal Model Arterial PTA Placement
*Animal study (repeat PTA in
swine artery) was performed by
3 physicians who tested the
Lutonix® 035 DCB (no drug)
and the Ultraverse® 035 PTA
Catheter, both with GeoAlign®
Markers, to POBA with no
GeoAlign® Markers (n=112, test
n=96 (with an average
placement time of 66 seconds),
control n=16 (with an average
placement of 90 seconds)).
Animal data on file. Bard.
Animal test results may not be
indicative of clinical
performance. Different test
methods may yield different
results.
BPV/LTNX/1015/0002
Seco
nd
s
(Avera
ge
)
![Page 8: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/8.jpg)
Radiation Facts
Findings*: • Image guided medical procedures using interventional fluoroscopy are the leading
source of occupation ionizing radiation exposure for medical personnel
• Risk of cancer increases linearly with increasing doses
• Average ionizing radiation head exposure to an IC over a 20 year career = 1,000 mSv
o 1,000 mSv correlated to a 5% risk of cancer
*All Findings sourced from ORSIF White Paper and ORSIF Poster. www.orsif.org 2015
![Page 9: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/9.jpg)
Disease
Description:
•Mid SFA stenosis
•Total occlusion
•De novo lesion
•Rutherford 4
•Diabetic
•Two vessel runoff BTK
Patient Runoff
![Page 10: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/10.jpg)
Patient Runoff (Cont…) Disease
Description:
•Mid SFA stenosis
•Total occlusion
•De novo lesion
•Rutherford 4
•Diabetic
•Two vessel runoff BTK
![Page 11: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/11.jpg)
Pre-Dilatation* 5 x 250mm PTA Balloon
*When the catheter is
exposed to the vascular
system, the location of
the balloon should be
confirmed while under
high quality
fluoroscopic
observation
GEOALIGN® Marker = 92cm
![Page 12: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/12.jpg)
Post Pre-Dilatation Angiogram
![Page 13: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/13.jpg)
Drug Coated Balloon*
* The LUTONIX®
Catheter should
always be
manipulated under
fluoroscopic
observation when in
the body
6 x 150mm PTA Balloon
GEOALIGN® Marker = 93cm (to distal lesion)
![Page 14: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/14.jpg)
Alignment
Pre-Dilatation
GEOALIGN® Marker = 92cm
DCB
GEOALIGN® Marker = 93cm
5 x 250mm PTA Balloon
6 x 150mm PTA Balloon
10mm Overlap
![Page 15: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/15.jpg)
Post DCB Angiogram
![Page 16: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/16.jpg)
GeoAlign® Marking System is designed to facilitate
repeat catheter alignment at the lesion
GeoAlign® Marking System helps promote efficiency
when aligning the DCB to the pre-dilatation balloon,
thereby helping to reduce fluoroscopy exposure
Summary
![Page 17: Optimizing lesion cross ability and accuracy by reducing ...€¦ · Speaker name: Pawanrat Kranokpiraksa I have the following potential conflicts of interest to report: Consulting](https://reader036.vdocuments.mx/reader036/viewer/2022071219/6055981ac269d226991fe7ba/html5/thumbnails/17.jpg)
Optimizing lesion cross ability
and accuracy by reducing
fluoroscopy time and radiation
exposure
Pawanrat Kranokpiraksa, MD
Interventional Radiology
Chulalongkorn University Bangkok, Thailand